Institute for Advanced Discovery & Innovation
Richard Berman is the associate vice president of strategic initiatives for the University of South
Florida (USF) Research & Innovation, visiting social entrepreneurship professor in
the Muma College of Business, and a professor in the institute. A recognized global
leader in health care education and management, he has consulted for the Commissioner
of the U.S. Food and Drug Administration, the U.S. Department of Health and Human
Services, McKinsey & Company, and the government of Rwanda. He has served as New York
State Commissioner of Housing and Economic Development and trustee of the State University
of New York, as well as on the Commission on Advancement of Racial and Ethnic Equality
of the American Council on Education, the Division III President's Council of NCAA,
ProPAC, and the New York State's Commissioner's Advisory Council on Higher Education.
He was advisor to the Joint Special Representative of the African Union—United Nations
Mission in Darfur (UNAMID)—the then-largest peacekeeping operation in the world. As
a leader in the field of education, he has served in several capacities, most notably
as the tenth president of Manhattanville College and as the Interim dean of the Patel
College of Global Sustainability at USF. Previously, he was the executive vice president
of NYU Medical Center and professor of health care management at the NYU School of
Medicine. He is a member of the National Academy of Medicine and has served on the
boards of EmblemHealth, Seeds of Peace, and the Savannah Centre for Diplomacy, Democracy
and Development in Abuja, Nigeria. He received his B.B.A., MBA, and M.P.H. from the
University of Michigan in Ann Arbor and holds honorary doctorates from Manhattanville
College and New York Medical College.
Peter Bridenbaugh is a professor in the institute and was an executive vice president of Alcoa until
his retirement in 1998. After receiving a bachelor's degree in mechanical engineering
and a master's degree in metallurgy from Lehigh University and a Ph.D. in materials
science from the Massachusetts Institute of Technology (MIT), he joined Alcoa in 1968.
At Alcoa, he served as the executive vice president and chief technical officer of
Alcoa Laboratories, leading all of the R&D, engineering, and health and safety operations.
In 1994, he was assigned direct responsibility for Alcoa's automotive market operations
as well, where he was instrumental in expanding the use of aluminum in automobiles
and integrating Alcoa's technical and commercial initiatives in the automotive market.
Bridenbaugh has shared his technical expertise by serving on various corporate and
advisory boards, acting as the double subject editor—corrosion and nonferrous metals—for
the Encyclopedia of Materials: Science and Technology, and serving on the advisory committee for writing the history of Corning, Inc. He
has chaired national conferences for the Federation of Materials Societies and the
Industrial Research Institute (IRI). He is a member of the NAE, Sigma Xi, the American
Institute of Mining, Metallurgical, and Petroleum Engineers (AIME), the American Society
for Metals (ASM), The Minerals, Metals and Materials Society (TMS), the Materials
Research Society (MRS), and IRI. He is also the recipient of various honors, including
the National Materials Advancement Award, Federation of Materials Societies; Hoyt
Lecture, American Foundryman's Society; fellow, ASM International; Zae Jeffries Lecture,
ASM; Leadership Award, TMS; Alpha Sigma Mu Lecture, ASM-TMS; Andrew Carnegie Lecture,
ASM; Distinguished Lecture on Materials and Society, ASM-TMS and ASM Honorary Membership-2004.
Robert H. Byrne is a Distinguished University Professor in the College of Marine Science at USF and
a professor in the institute. He holds a B.S. degree in physics from the University
of Chicago, an M.S. in physics from DePaul University, an M.A. in chemistry from Boston
University, and a Ph.D. in oceanography from the University of Rhode Island. He has
made important contributions in the field of marine physical chemistry — specifically,
investigating the speciation of trace metals in seawater, developing new procedures
for characterizing the carbon dioxide (CO2) system in aqueous environments, and designing
new instrumentation for measuring nutrients, trace elements, and CO2 system constituents
in freshwater and seawater. His field research has included more than 560 days at
sea in the Gulf of Mexico and the Atlantic, Pacific, Indian, and Arctic Oceans. He
holds fourteen U.S. and international patents and is one of the co-founders of Ocean
Optics, Inc. He has written 200 peer-reviewed publications, serving as first or second
author on two-thirds of these. He has also served as a reviewer and editor for various
agencies and academic journals, including more than two decades as an associate editor
for the journal Geochemica et Cosmochimica Acta. He is a fellow of the American Geophysical Union, the AAAS, and the NAI.
Harry P. Cain II is a professor in the Institute for Advanced Discovery & Innovation and was the executive
vice president of the Blue Cross and Blue Shield Association (BCBSA) until his retirement
in 2000. He holds a B.A. in political science from Stanford University, an M.A. in
Political Science from the University of Washington, and a Ph.D. in social policy
from Brandeis University. He began his career in government service in the (then)
Department of Health, Education, and Welfare, becoming assistant director of the National
Institute of Mental Health, then director of the policy office for the Assistant Secretary
for Health, then director of the Bureau of Health Planning and Resource Development,
where he was responsible for the implementation of the National Health Planning and
resources Development Act of 1973. He later moved on to Blue Cross/Blue Shield, where
he served in various leadership positions, including administering the Blue Cross
Medicare prime contract and the Blue Cross Blue Shield components of the Federal Employees
Health Benefits Program. Post retirement he taught in the Graduate School of Business,
College of William and Mary, and in their adult education program. He also consulted
with the Blues on healthcare reform from 2008-13. He was elected as a member of the
NAM in 1997 for excellence in health services, education, and research. He is the
author of numerous papers on health planning, insurance, Medicare, and related health
policy topics, and has frequently been called to testify before Congress on a wide
array of public health issues.
William Cavanaugh III is a professor emeritus in the institute and was the chairman and CEO of Progress
Energy until his retirement in 2004. After completing his BS in mechanical engineering
at Tulane University in 1961, he joined the U.S. Navy and became a nuclear submarine
officer. Upon his honorable discharge, he began his long and productive career in
the utility industry, holding key executive positions at Arkansas Power & Light, Louisiana
Power & Light, and Mississippi Power & Light. His success in guiding these companies
led to his taking over Carolina Power & Light, where he served as president and COO
and later as CEO and chairman, leading the company to financial success and new levels
of efficiency in its operations and power generation. In 2000, he negotiated the purchase
of Florida Progress Corporation, merging it with CP&L to become Progress Energy, a
Fortune 500 energy company serving over three million customers. After his retirement
from Progress Energy, he became chairman of the World Association for Nuclear Operations
(WANO), where he oversaw the institution of a mandatory peer review process for member
organizations, among other initiatives. He was elected as a member of the NAE in 2001
for "contributions to excellence in the generation of electricity from nuclear power
by establishing and achieving exemplary levels of performance." He has received the
William S. Lee Award for Industry Leadership from the Nuclear Energy Institute and
the Walter H. Zinn Award from the American Nuclear Society.
Selim Chacour is a professor in the institute and was the principal founder of American Hydro Corporation,
which, under his leadership, became an industry leader in hydro turbine upgrades.
In his industry, he is hailed for various improvements to the design of turbine components
and for completely revolutionizing runner design by creating computer design programs
which obviated the need for physical model testing, the previous standard. This work
had a great impact on hydro plants already in existence, allowing them to upgrade
their facilities and improve performance. His turbine runner designs have been used
in such iconic structures as the Aswan High Dam in Egypt and the Hoover Dam in the
United States. Additionally, his designs have generated concrete improvements in efficiency,
resulting in gains in power generation and reductions in costs and environmental impact.
Lauded as a visionary, he was elected as a member of the NAE "for pioneering three-dimensional
finite element computations in mechanical and hydraulic design, leadership in hydro
turbine research and development, and business stewardship," highlighting his status
as an innovator and as a business leader. He is also the recipient of the National
Hydropower Association's Henwood Award, the industry's highest honor, and holds eight
U.S. patents for his work. In 2015, he became a fellow of the NAI.
David M. Eddy is a professor in the institute and a physician, mathematician, and health care analyst
who has done seminal work in mathematical modeling of diseases, clinical practice
guidelines, and evidence-based medicine. In summarizing his career, the NAM (of which
he is a member) emphasized his innovative thinking and practices, noting that "more
than 25 years ago, Eddy wrote the seminal paper on the role of guidelines in medical
decision-making, the first Markov model applied to clinical problems, and the original
criteria for coverage decisions; he was the first to use and publish the term 'evidence-based'."
He was a professor at Stanford University and the J. Alexander McMahon Professor at
Duke University before he left academia to become an independent researcher and entrepreneur.
He founded Archimedes Inc., a health care modeling company, and was chief medical
officer until he retired in 2013. The author of five books and more than 100 first-authored
papers, including a series of 28 in the Journal of the American Medical Association, his writings span from technical mathematical theories to broad health policy topics.
He has received 10 national and international awards in several fields, including
applied mathematics, health technology assessment, health care quality, environmental
sciences, and outcomes research, as well as awards from five organizations for lifetime
achievement. In 2012, he was ranked the 13th most innovative person in health care
by "Health Future 100." In 2015, he became a fellow of the NAI. He holds two U.S.
Since 2002, Michael W. Fountain has served as the founding director of USF's Center for Entrepreneurship, which has
been ranked by Princeton Review and Entrepreneur Magazine as one of the top 25 graduate entrepreneurship educational programs in the United
States for the past 10 consecutive years. He is a professor in industrial and management
systems engineering, psychiatry and behavioral medicine, and pharmacy; the John and
Beverley Grant Endowed Chair in Entrepreneurship in the Muma College of Business;
and a professor in the institute. He holds more than 60 U.S. and foreign patents,
which are used in over 150 healthcare and consumer products worldwide. He has served
as entrepreneur-in-residence at the Ewing Marion Kauffman Foundation. He is a fellow
of the National Academy of Inventors and a founding member of its USF chapter. He
is also a Justin Logernecker Fellow of the United States Association for Small Business
and Entrepreneurship. He has focused the past 35 years on creating, financing, growing,
and harvesting biotechnology, medical device, and life sciences companies. He has
founded or co-founded 12 new ventures, three of which became publicly traded companies.
He has served in a variety of corporate leadership roles, including chief scientific
officer, chief executive officer, president and chairman of the board of directors.
He currently serves on the board of directors of Intezyne, Global Safety Management,
Inventivv, and Liberty Defense Systems. He is the author of numerous peer reviewed
articles on micro- and nano-drug delivery systems and entrepreneurship theory and
practice. He received his Honors B.S. from Samford University, his M.S. and Ph.D.
from Auburn University, and his MBA from Bristol University.
Richard D. Gitlin is a State of Florida 21st Century World Class Scholar, Distinguished University
Professor, the Agere Systems Endowed Chair in Electrical Engineering at the University
of South Florida, and a professor in the institute. He has more than 45 years of leadership
in the communications industry and in academia, and he has a record of significant
research contributions that have been sustained and prolific over several decades.
His research focuses on the intersection of communications with medicine, especially
in vivo wireless communications and networking that is used to advance minimally invasive
surgery and other cyber-physical health care systems, as well as the emerging 5G wireless
and IoT wireless networks. Before joining the faculty at USF, Gitlin was at Bell Labs/Lucent
Technologies, where he was the co-inventor of Digital Subscriber Line (DSL), and,
at his retirement, he was senior vice president for communications and networking
research. He is a member of the National Academy of Engineering, Fellow of the Institute
of Electrical and Electronics Engineers, Bell Laboratories Fellow, Charter Fellow
of the National Academy of Inventors, co-recipient of the Thomas Alva Edison Patent
Award and the S.O. Rice Prize, and a 2017 inductee of the Florida Inventors Hall of
Fame. He has co-authored a text, has published 100 papers, and holds 63 U.S. patents.
He is currently working on MARVEL, a robotic imaging system used to aid minimally
invasive surgery, and a new form of electrocardiogram, the vectorcardiogram, that
provides 24/7 diagnostic quality cardiac care information in a compact personal device
that can indicate and potentially predict cardiac events. His 5G research is directed
towards ultra-reliable and low latency networking.
D. Yogi Goswami is Distinguished University Professor, director of the Clean Energy Research Center
at USF, and a professor in the institute. His research focuses on solar energy fundamentals
and applications, energy storage, thermodynamics, indoor air quality (IAQ), HVAC,
hydrogen, and fuel cells. He is editor-in-chief of Solar Energy and Progress in Solar Energy and author/editor of 21 books and over 350 refereed papers. He also holds 19 U.S.
patents, some of which have been commercialized around the world. He is a National
Academy of Inventors Charter Fellow and a 2016 inductee of the Florida Inventors Hall
of Fame. He is also a fellow of the American Society of Mechanical Engineers International
(ASME-International), the American Association for the Advancement of Science, the
American Society of Heating, Refrigerating and Air-Conditioning Engineers, the International
Solar Energy Society (ISES), and the American Solar Energy Society (ASES), as well
as a member of the Pan American Academy of Engineering. He has received the ISES'
Farrington Daniels Award, ASME's Frank Kreith Energy medal, ASME's John Yellott Award
for Solar Energy, the ASES' Charles Greely Abbott award, and more than 50 additional
awards from various scientific and engineering professional societies. He has served
as a governor of ASME-International (2003-2006), president of the ISES (2004-2005),
senior vice president of ASME (2000-2003), and president of the International Association
for Solar Energy Education (2000-2002).
Donald Keck is a professor in the institute and was the vice president and executive director
of research at Corning, Inc. He has a B.S., M.S., and Ph.D. in physics from Michigan
State University (MSU). After graduating from MSU, he took a position at Corning Inc.
in 1968 working with Robert Maurer. Working collaboratively with Maurer and Peter
Schultz over the next two years, he made seminal contributions to fiber optics. Inventing
a series of material and processing concepts, they were able to improve the transparency
of fused silica and doped fused silica glasses by nearly 100 orders of magnitude.
This enabled optical communications and established optical fiber rather than copper
wire as the key communication conduit. Their work, in reality, enabled the internet.
More than 3.7 billion kilometers of optical fiber based on their inventions encircle
the planet. Keck is recognized as a pioneer in optical fiber communications for this
work. Continuing at Corning, he became vice president and executive director of research,
retiring in 2002. He holds 38 patents and has authored more than 150 papers on optical
fibers and related topics. Among his many honors are the National Medal of Technology
from President Clinton; induction into the National Inventors Hall of Fame; the John
Tyndall award from The Optical Society (OSA) and the IEEE Photonics Society; the U.S.
Department of Commerce American Innovator Award; the SPIE Technology Achievement Award;
and Laurin Publishing's Distinction in Photonics Award. He has an honorary doctorate
from Rensselear Polytechnic Institute, is an honorary member of OSA, and a fellow
of the Institute of Electrical and Electronics Engineers (IEEE). He served as editor
of the IEEE/OSA Journal of Lightwave Technology and generously donated his time to the OSA community. After retirement, Keck helped
established the Infotonics Technology Center in Canandaigua, New York, and is now
working with USF.
Stephen B. Liggett is associate vice president for research at USF Health, vice dean for research at
the Morsani College of Medicine, professor of internal medicine and molecular pharmacology
and physiology, and a professor in the institute. He discovered and characterized
receptor polymorphisms. He was the first to discover polymorphisms of the G-protein
coupled receptor superfamily, to which more than 50% of all drugs are targeted. This
discovery moved the field of pharmacogenomics from one that concentrated on metabolizing
enzymes to one that includes target proteins for determining drug responsiveness.
He also developed biotechnical companies related to personalized medicine based on
these discoveries. His fundamental studies in humans and genetically altered mice
have led to new advances in the areas of heart failure, hypertension, and obstructive
lung diseases. He holds 16 U.S. patents and has more than 250 publications. He is
a fellow of the American College of Chest Physicians and the National Academy of Inventors,
as well as the recipient of the Frontiers in Pharmacology Award from Case Western
Reserve University and Excellence in Science Award from Thomas Jefferson University.
Charles J. Lockwood, senior vice president of USF Health, dean of the Morsani College of Medicine at
USF, and professor in the institute, is internationally known for research expertise
in uterine hemostasis and preterm birth. Previously, he was dean of The Ohio State
University College of Medicine; Anita O'Keeffe Young Professor and chair of obstetrics
and gynecology at the Yale School of Medicine and chair of the Yale Medical Group
board; and chair of obstetrics and gynecology at the NYU School of Medicine and interim
director of their NCI-designated Cancer Center. He graduated from Brown University,
magna cum laude, received his MD from the University of Pennsylvania, served an OB-GYN
residency at Pennsylvania Hospital and a Maternal-Fetal Medicine fellowship at Yale.
He also holds a master's in health care management from the Harvard School of Public
Health. He has garnered multiple NIH and March of Dimes grants and published over
290 peer reviewed papers (h-index of 66; > 11,000 citations). He has co-edited five
obstetrical textbooks, three with multiple editions; serves on multiple editorial
boards; and is the long-standing editor-in-chief of Contemporary OB/GYN, where his
editorials have garnered five national publishing awards. He has served on or chaired
multiple NIH study sections, chaired FDA and American College of Obstetricians and
Gynecologists committees, is president-elect of the American Gynecological and Obstetrical
Society, and sits on the boards of the National March of Dimes Foundation, American
Association of Obstetricians and Gynecologist foundation and the Society for Maternal
Fetal Medicine Foundation. He is a member of the Sigma Xi and Alpha Omega Alpha honor
societies, former president of the Society for Reproductive Investigation and winner
of its Pardi Distinguished Scientist Award, and a member of the National Academy of
Medicine and a fellow of the American Association for the Advancement of Science.
He maintains an active research lab at USF.
Dean F. Martin has spent most of his academic career at the University of South Florida, where he
has been a member of the faculty since 1964 as an associate professor (1964-1969),
professor (1969-93), and distinguished professor (1993-2016) before being granted
emeritus status. He is also a professor in the institute. Previously, he was a member
of the faculty of the University of Illinois as instructor and assistant professor
of inorganic chemistry (1959 1964). He received his education at Grinnell College
(B.A., 1955), The Pennsylvania State University (Ph.D., 1958), and University College
London, where he was a National Science Foundation post doctoral fellow (1958-59).
He and his wife, Barbara B. Martin, are parents of a daughter and five sons. They
have shared research interests concerned with the coordination chemistry of natural
water systems, including problems of red tide and aquatic weeds, as well as removal
of nuisance chemical species by means of chelating agents covalently attached to silica.
The Martins were editors of the Florida Scientist from 1984-2010. They have about 80 joint publications, and Dean Martin is the author
or co author of over 450 publications, including six books. He received (1969 1974)
a Career Development Award from the Division of General Medical Sciences, National
Institute of Health (NIH), to study the chemistry and chemical environment of algal
toxins. In 1970 71, he was a visiting professor of physiology and pharmacology at
Duke University Medical Center. The Martins have been able to engage in philanthropic
activities through creation of endowments, including five at Grinnell College, two
at Penn State, and ten at USF. They are also strong supporters of USF's three ROTC
Shyam S. Mohapatra is Distinguished Health Professor; director of the Division of Translational Medicine
and of the Center for Research and Education in Nanobioengineering at the University
of South Florida (USF) Department of Internal Medicine, where he has been a faculty
member since 1996; and a professor in the institute. Recipient of two international
awards (Alexander Von Humboldt Research Fellow and Pharmacia Allergy Research Foundation
Award) early in his career, in the last two decades, he has been internationally recognized
for his many inventions in the field of nanoscale biomedical diagnostics and therapeutics
in cancers, asthma, viral infections, and traumatic brain injury. In cancers, his
inventions have led to several technology platforms and products for innovative anti-cancer
drug discovery, drug development, and personalized cancer treatment. His research
has brought USF over $26 million in extramural funds, and he has published over 200
papers and holds over 35 U.S. and foreign patents. He is also the founding associate
dean of graduate programs at the USF College of Pharmacy and has established a cutting-edge,
highly innovative Master of Science program in pharmaceutical nanotechnology. As a
research career scientist at the James A. Haley VA Hospital in Tampa, Dr. Mohapatra
has recently founded a Veteran Affairs cellgenomics collaborative on colorectal cancers
(VA4C), which includes clinical and research investigators from about a dozen VA hospitals/universities
in the nation, which aims to utilize cellgenomic approach to individualize cancer
treatment. His research has spawned inventions that have spun out companies. He co-founded
Transgenex Nanobiotech Inc, a USF spin-out company that focuses on commercializing
nanoscale innovations. He is a Charter Fellow of the National Academy of Inventors;
a fellow of the American Academy of Allergy, Asthma & Immunology, American Association
of Medical and Biological Engineers, and American Association of Advancement of Science;
and is a 2014 inductee of the Florida Inventors Hall of Fame. He obtained his Ph.D.
from the Australian National University, Canberra, Australia, and his MBA from the
University of South Florida.
Victor Poirier is a professor in the institute and former CEO and president of Thermo Cardiosystems
and chief technology advisor of Thoratec Corp. Two public companies that he formed
that were traded on the American Stock Exchange. He is internationally recognized
as a pioneer for the design, development, clinical trial, and commercialization of
left-ventricular assist systems for treating heart failure. His technology resulted
in the first FDA approvals of four different implantable devices designed to take
over the pumping function of the natural heart, and two of those devices were also
approved for permanent use as an alternative to a biologic heart transplant with a
third device in the approval process. Over approximately 35,000 devices have been
implanted to date for periods exceeding 13 years. He is a founding fellow of the American
Institute for Medical and Biological Engineering and the International Academy of
Artificial Organ Pioneers of the International Center for Medical Technologies, a
fellow of the National Academy of Inventors, and a member of the National Academy
of Engineering. He is the recipient of the Mediterranean Institute of Cardiology Award
(France), the Himet Award, and the Barney Clark Award from the American Society for
Artificial Internal Organs and was elected by his peers as the national "Engineer
of the Year" (Design News, 1992), among other honors and awards. He holds 18 U.S.
patents and has published over 110 papers. He is currently exploring ways to teach
innovation and innovative thinking practices and was lead author on a publication,
the first of a series, exploring that topic.
Paul R. Sanberg is senior vice president for research, innovation and knowledge enterprise; Distinguished
University Professor of neuroscience, biomedical engineering, computer science and
engineering, and business at the University of South Florida; executive director of
the Center of Excellence for Aging & Brain Repair; and founder and president of the
National Academy of Inventors (NAI). He is an inventor on 157 U.S. and foreign patents
and has worked as an executive with a number of start-up companies involved in cell
therapy for degenerative disorders. His work has been instrumental in translating
novel pharmaceutical and cellular therapeutics to clinical trials for Tourette syndrome,
depression, stroke, Huntington's disease, Parkinson's disease, ALS, and Alzheimer's
disease. He is the 2016 recipient of the John P. McGovern Science & Society Award;
2015 Medalist of the Florida Academy of Sciences; a 2015 inductee of the Florida Inventors
Hall of Fame; fellow of the American Association for the Advancement of Science (AAAS),
American Institute for Medical and Biological Engineering, and Royal Societies of
Chemistry, Public Health, and Medicine; Charter Fellow of the NAI; and inaugural AAAS-Lemelson
Invention Ambassador. He serves on the nomination evaluation committee of the United
States National Medal of Technology and Innovation with the U.S. Department of Commerce,
Smithsonian Innovation Festival selection committee, and advisory board of the Association
of Public and Land-grant Universities Commission on Innovation, Competitiveness, and
Economic Prosperity. He has published more than 650 scientific articles and 14 books.
Sudeep Sarkar is professor and chair of computer science and engineering in the USF College of
Engineering, associate vice president for I-Corps at USF, and a professor in the institute.
He has more than 25 years of experience conducting and directing fundamental and applied
research in computer vision, image processing, and pattern recognition. He developed
a new imaging device that can be used to collect data about the physical characteristics
of human skin in terms of its color, texture, and elasticity, which is critical in
diagnosing diseases such as melanoma. He is also a pioneering leader in the area of
gait biometrics, a field that analyzes and catalogs the unique characteristics of
the ways in which individuals walk. This development for identity detection has potential
uses in security and threat assessment, as well as environmentally-aware electronic
devices and smart rooms. Sarkar is also a leader in the development of recognition
systems to translate videos of sign language into text to facilitate communication
between hearing-impaired and hearing individuals. He holds four U.S. patents and has
published high-impact journal and conference papers. He received his M.S. and Ph.D.
degrees in electrical engineering, on a University Presidential Fellowship, from The
Ohio State University. He is the recipient of the National Science Foundation CAREER
award in 1994, the USF Teaching Incentive Program Award for Undergraduate Teaching
Excellence in 1997, the Outstanding Undergraduate Teaching Award in 1998, and the
Theodore and Venette Askounes-Ashford Distinguished Scholar Award in 2004. He is a
fellow of the American Association for the Advancement of Science, National Academy
of Inventors, American Institute of Medical and Biological Engineers, Institute of
Electrical and Electronics Engineers, and International Association for Pattern Recognition
(IAPR) and a charter member and member of the board of directors of the National Academy
Lyle H. Schwartz is a professor in the institute and retired director, Air Force Office of Scientific
Research. He was formerly professor of materials science and engineering at Northwestern
University for 20 years and director of Northwestern's Materials Research Center for
five of those years. He then became director of the Materials Science and Engineering
Laboratory at the National Institute of Standards and Technology (NIST), where he
served for more than 12 years. After NIST, he moved to the Air Force Office of Scientific
Research, where, as director, he had responsibility for the entire basic research
program of the Air Force. He has played a significant role in shaping government policies
on many materials issues. He was elected as a member of the NAE for "leadership in
materials research and in coordinating industry and government collaboration in materials
engineering." He is a recipient of the Presidential rank of Meritorious Executive
of the government's Senior Executive Service, the Gold Medal Award of the Department
of Commerce, the National Materials Advancement Award of the Federation of Materials
Societies, and the Leadership Award of the Minerals, Metals, and Materials Society.
His current interests include government policy for R&D, particularly for materials
R&D, materials science education (STEM) at K-12 levels, and enhanced public understanding
of the roles and importance of technology in society. He is bringing his interests
in K-12 education to bear in the Tampa area as part of his commitment to USF and the
Thomas M. Weller is professor and chair of electrical engineering at USF and a professor in the institute.
He received his B.S., M.S., and Ph.D. degrees in electrical engineering from the University
of Michigan, Ann Arbor. Before becoming chair of electrical engineering, he served
as the associate dean for research in the USF College of Engineering from 2008-2012.
Weller has made important contributions to reconfigurable microwave circuits, microwave
applications of additive manufacturing and 3D printing, electromagnetic sensors, and
equivalent circuit modeling. He is a co-recipient of the 1996 Microwave Prize from
the Institute of Electrical and Electronics Engineers Microwave Theory & Techniques
Society (MTT-S), a recipient of a CAREER Award from The National Science Foundation
in 1999, and a recipient of the Outstanding Young Engineer Award from the MTT-S in
2005. He holds 30 U.S. patents and is a co-founder of Modelithics, Inc., which provides
custom microwave modeling services and CAE model libraries. He has published over
280 peer-reviewed articles and book chapters and served as principal or co-principal
investigator on more than 110 externally funded research projects.
James Wynne is a professor in the institute and a senior member of the staff of IBM Research Headquarters. He manages the T. J. Watson Research Center's outreach to local schools and coordinates IBM's global participation in DiscoverE, serving as a catalyst to marshal the resources of IBM to enhance the Science, Technology, Engineering and Mathematics (STEM) education of K-12 students. His research contributions have been in nonlinear optics of semiconductors and insulators, nonlinear spectroscopy of atomic and molecular vapors, laser etching and fluorescence studies of human and animal tissue, and cluster science. He and two IBM colleagues discovered excimer laser surgery in 1981, laying the foundation for LASIK and PRK, techniques for surgically correcting myopia, astigmatism, and hyperopia. For this discovery, he has received many awards, including induction into the NIHF, the National Medal of Technology and Innovation, and the Russ Prize of the National Academy of Engineering (NAE). He is a member of the NAE, fellow of the NAI, member of the USF Chapter of the NAI, and a research collaborator with USF faculty. He holds 12 U.S. patents. His current research encompasses the development of novel applications of the excimer laser, especially its use as a "smart scalpel" for removing necrotic lesions of the skin while minimizing collateral damage to underlying and adjacent viable tissue.